Skip to main content

Table 1 Demographic and baseline characteristics of participants

From: Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial

  Liquid Kaloba® (n = 42) Liquid placebo (n = 40) Tablet Kaloba® (n = 26) Tablet placebo (n = 26) All participants
Female 19/42 (45.2%) 26/40 (65.0%) 15/26 (57.7%) 16/26 (61.5%) 76/134 (56.7%)
Mean age (SD) 56.64 (14.41) 56.65 (17.24) 59.23 (12.31) 57.27 (17.89) 57.27 (15.52)
Ethnicity
 ➙White 30/31 (96.8%) 27/27 (100.0%) 20/21 (95.5%) 21/22 (95.5%) 98/101 (97.0%)
 ➙Mixed 0/31 (0.0%) 0/27 (0.0%) 0/21 (0.0%) 1/22 (4.6%) 1/101 (1.0%)
 ➙Asian/Asian-British 1/31 (3.2%) 0/27 (0.0%) 0/21 (0.0%) 0/22 (0.0%) 1/101 (1.0%)
 ➙Prefer not to answer 0/31 (0.0%) 0/27 (0.0%) 1/21 (4.6%) 0/22 (0.0%) 1/101 (1.0%)
Employment
 ➙Full/part time 18/31 (58.1%) 13/26 (50.0%) 10/21 (47.6%) 11/22 (50.0%) 52/100 (52.0%)
 ➙Unable to work 1/31 (3.2%) 1/26 (3.9%) 1/21 (4.8%) 0/22 (0.0%) 3/100 (3.0%)
 ➙Retired 11/31 (35.5%) 11/26 (42.3%) 10/21 (47.6%) 11/22 (50.0%) 43/100 (43.0%)
 ➙Full time education 0/31 (0.0%) 1/26 (3.9%) 0/21 (0.0%) 0/22 (0.0%) 1/100 (1.0%)
 ➙Not working for other reasons 1/31 (3.2%) 0/26 (0.0%) 0/21 (0.0%) 0/22 (0.0%) 1/100 (1.0%)
Smoking habits
 ➙Never 15/30 (50.0%) 11/27 (40.7%) 7/21 (33.3%) 10/22 (45.5%) 43/100 (43.0%)
 ➙Past 14/30 (46.7%) 14/27 (51.9%) 13/21 (61.9%) 8/22 (36.7%) 49/100 (49.0%)
 ➙Current 1/30 (3.3%) 2/27 (7.4%) 1/21 (4.8%) 4/22 (18.2%) 8/100 (8.0%)
Health conditions
 ➙Hypertension 11/42 (26.2%) 9/40 (22.5%) 7/26 (26.9%) 4/26 (15.4%) 31/134 (23.1%)
 ➙CVD 1/42 (2.4%) 3/40 (7.5%) 0/26 (0.0%) 1/26 (3.9%) 5/134 (3.7%)
 ➙Lung disease/COPD 0/42 (0%) 1/40 (2.5%) 2/26 (7.7%) 0/26 (0%) 3/134 (2.2%)
 ➙Diabetes 5/42 (11.9%) 3/40 (7.5%) 3/26 (11.5%) 1/26 (3.9%) 12/134 (9.0%)
 ➙Asthma 9/42 (21.4%) 8/40 (20.0%) 3/26 (11.5%) 3/26 (11.5%) 23/134 (17.2%)
Antibiotic Prescription
 ➙No 25 (59.5%) 29 (72.5%) 12 (46.2%) 14 (53.8%) 80/134 (59.7%)
 ➙Delayed Use 3 (7.1%) 3 (7.5%) 7 (26.9%) 8 (30.8%) 21/134 (15.7%)
 ➙Immediate Use 14 (33.3%) 8 (20.0%) 7 (26.9%) 4 (15.4%) 33/134 (24.6%)
  1. 1: Symptom severity was scored 0–6 (0 = Normal/not affected; 1 = Very little problem; 2 = Slight problem; 3 = Moderately bad; 4 = Bad; 5 = Very bad; 6 = As bad as it could be)
  2. LQ – Lower quartile; UQ – Upper quartile